Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing a lawsuit that could ...

New studies found that Americans with type 2 diabetes who are taking GLP-1 drugs like Ozempic and Mounjaro could face an ...

Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...

One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...

Could diabetes and weight loss drugs like Ozempic (semaglutide) also protect the brain from ... lower initial death rate—just 5.26 percent compared to 21.61 percent for non-users. Long-term survival ...

Ozempic faces over 1,800 lawsuits in US courts, with damages possibly topping $2 billion. Patients allege the drug caused ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

Novo Nordisk said on Monday it is offering its diabetes drug Ozempic for $499 per month to eligible cash-paying type 2 ...

Ozempic is typically only covered by insurance when prescribed to treat type 2 diabetes, or type 2 diabetes that coexists ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug is prescribed for something it’s not approved for.

The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...

A clinical trial has shown that Ozempic improves blood glucose levels and weight loss in overweight type 1 diabetics who use an automated insulin delivery system. It’s hoped that this will lead ...